179 related articles for article (PubMed ID: 38035706)
1. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
Terasaki M; Tsuruoka K; Tanaka T; Maeda H; Shibata M; Miyashita K; Kanemitsu Y; Sekine S; Takahashi M; Yagishita S; Hamada A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):686-705. PubMed ID: 38035706
[TBL] [Abstract][Full Text] [Related]
2. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
[TBL] [Abstract][Full Text] [Related]
3. Fucoxanthin Prevents Pancreatic Tumorigenesis in C57BL/6J Mice That Received Allogenic and Orthotopic Transplants of Cancer Cells.
Murase W; Kamakura Y; Kawakami S; Yasuda A; Wagatsuma M; Kubota A; Kojima H; Ohta T; Takahashi M; Mutoh M; Tanaka T; Maeda H; Miyashita K; Terasaki M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948416
[TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
Terasaki M; Iida T; Kikuchi F; Tamura K; Endo T; Kuramitsu Y; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2019 Feb; 64():198-205. PubMed ID: 30530259
[TBL] [Abstract][Full Text] [Related]
5. Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin.
Terasaki M; Ono S; Hashimoto S; Kubota A; Kojima H; Ohta T; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2022 Jan; 99():108871. PubMed ID: 34571188
[TBL] [Abstract][Full Text] [Related]
6. Fucoxanthin and Colorectal Cancer Prevention.
Terasaki M; Kubota A; Kojima H; Maeda H; Miyashita K; Kawagoe C; Mutoh M; Tanaka T
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069132
[TBL] [Abstract][Full Text] [Related]
7. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
9. A Biscuit Containing Fucoxanthin Prevents Colorectal Carcinogenesis in Mice.
Terasaki M; Murase W; Kamakura Y; Kawakami S; Kubota A; Kojima H; Ohta T; Tanaka T; Maeda H; Miyashita K; Mutoh M
Nutr Cancer; 2022; 74(10):3651-3661. PubMed ID: 35695489
[TBL] [Abstract][Full Text] [Related]
10. Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice.
Terasaki M; Uehara O; Ogasa S; Sano T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
Carcinogenesis; 2021 Feb; 42(2):210-219. PubMed ID: 32940665
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated
Terasaki M; Hamoya T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
Anticancer Res; 2021 Mar; 41(3):1299-1305. PubMed ID: 33788721
[TBL] [Abstract][Full Text] [Related]
12. Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice.
Terasaki M; Masaka S; Fukada C; Houzaki M; Endo T; Tanaka T; Maeda H; Miyashita K; Mutoh M
In Vivo; 2019; 33(2):365-374. PubMed ID: 30804114
[TBL] [Abstract][Full Text] [Related]
13. Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.
Yokoyama R; Kushibiki A; Yamada S; Kubota A; Kojima H; Ohta T; Hamada J; Maeda H; Mutoh M; Terasaki M
Cancer Genomics Proteomics; 2022; 19(4):428-444. PubMed ID: 35732323
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability-high colorectal cancer patient-derived xenograft models for cancer immunity research.
Suto H; Funakoshi Y; Nagatani Y; Imamura Y; Toyoda M; Kiyota N; Matsumoto H; Tanaka S; Takai R; Hasegawa H; Yamashita K; Matsuda T; Kakeji Y; Minami H
J Cancer Res Ther; 2021; 17(6):1358-1369. PubMed ID: 34916366
[TBL] [Abstract][Full Text] [Related]
15. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
16. A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell.
Terasaki M; Inoue T; Murase W; Kubota A; Kojima H; Kojoma M; Ohta T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(2):133-146. PubMed ID: 33608310
[TBL] [Abstract][Full Text] [Related]
17. Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model.
Terasaki M; Ikuta M; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905803
[TBL] [Abstract][Full Text] [Related]
18. Fucoxanthin bioavailability from fucoxanthin-fortified milk: In vivo and in vitro study.
Mok IK; Lee JK; Kim JH; Pan CH; Kim SM
Food Chem; 2018 Aug; 258():79-86. PubMed ID: 29655757
[TBL] [Abstract][Full Text] [Related]
19. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]